|
Category: pharmaceuticals / chemical synthisis
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Specific Gravity: | 3.98800 @ 25.00 °C.
|
| Vapor Pressure: | 33900.00000 mmHg @ 25.00 °C. (est) |
| Flash Point: | 32.00 °F. TCC ( 0.00 °C. ) (est)
|
Organoleptic Properties:
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| Preferred SDS: View |
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
intraperitoneal-mouse LD50 1460 mg/kg Comptes Rendus Hebdomadaires des Seances, Academie des Sciences. Vol. 256, Pg. 1043, 1963.
intravenous-mouse LD50 910 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 56(4), Pg. 118S, 1960.
oral-mouse LD50 2306 mg/kg Vestnik Akademii Meditsinskikh Nauk SSSR. Journal of the Academy of Medical Sciences of the USSR. Vol. (8), Pg. 10, 1978.
intravenous-rabbit LDLo 1000 mg/kg Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 56(4), Pg. 118S, 1960.
intraperitoneal-rat LD50 1500 mg/kg Archives of Industrial Hygiene and Occupational Medicine. Vol. 1, Pg. 637, 1950.
intravenous-rat LD50 1075 mg/kg VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD
KIDNEY, URETER, AND BLADDER: PROTEINURIS "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 244, 1999.
oral-rat LD50 2600 mg/kg Vestnik Akademii Meditsinskikh Nauk SSSR. Journal of the Academy of Medical Sciences of the USSR. Vol. (8), Pg. 10, 1978.
|
| Dermal Toxicity: |
subcutaneous-mouse LD50 2750 mg/kg KIDNEY, URETER, AND BLADDER: PROTEINURIS
VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 244, 1999.
subcutaneous-rat LD50 2590 mg/kg KIDNEY, URETER, AND BLADDER: PROTEINURIS
VASCULAR: BP ELEVATION NOT CHARACTERIZED IN AUTONOMIC SECTION
BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD "Spravochnik po Toksikologii i Gigienicheskim Normativam Vol. -, Pg. 244, 1999.
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | pharmaceuticals / chemical synthisis |
| Recommendation for cesium chloride usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for cesium chloride flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | caesium chloride | | | caesium(I) chloride | | | cesium chloride (CsCl) | | | cesium monochloride | | | cesiumchloride |
Articles:
|